1. Serpina3n: potential drug and challenges, mini review;Aslam,2020
2. Regulation of IGFBP-1 in metabolic diseases;Bae,2013
3. Selective versus total insulin resistance: a pathogenic paradox;Brown,2008
4. NAFLD: a multisystem disease;Byrne,2015
5. SERPINA3 silencing inhibits the migration, invasion, and liver metastasis of colon cancer cells;Cao,2018